Association between matrix metalloproteinase 9 C-1562T polymorphism and the risk of coronary artery disease: an update systematic review and meta-analysis.

Polymorphism (rs3918242) in the MMP9 gene has been reported to be associated with coronary artery disease (CAD). This study aims to investigate a more accurate estimation of the relationship between CAD and rs3918242 polymorphism by a meta-analysis method. We systematically searched studies on the association of rs3918242 polymorphism and CAD in PubMed, Web of Science, the Cochrane Library, Wanfang Data and CNKI. We used Stata 12.0 and RevMan 5.3 software to perform the meta-analyses. A total of 37 case-control studies involving 13,035 CAD patients and 11,372 non-CAD controls were included. A statistically significant association between rs3918242 polymorphism and CAD was observed in allelic model (Odds ratio (OR) 1.34; 95% confidence interval (CI) 1.20-1.50; < 0.00001), recessive model (OR 1.43; 95% CI 1.17-1.75; = 0.0004), and in dominant model ( OR 1.36; 95% CI 1.20-1.53; < 0.00001). Moreover, we also found that there is a statistically significant association between rs3918242 polymorphism and myocardial infarction (MI) in Asians with allelic model (OR 1.66; 95% CI 1.29-2.14; < 0.0001), recessive model (OR 2.29; 95% CI 1.44-3.63; = 0.004), and dominant (OR 1.74; 95% CI 1.29-2.35; = 0.0003) model. A similar result in Caucasians with allelic model (OR 1.14; 95% CI 1.02-1.27; = 0.02), and in dominant (OR 1.17; 95% CI 1.04-1.32; = 0.01) model. Our meta-analysis suggested that the MMP9 T allele is a risk factor for CAD and MI.